Sun Meijuan, Chen Yi, Sun Linsen, Deng Yu, Xu Xiaoxiao, Zhang Liang, Xiong Xiangsheng
Department of Anesthesiology, Huai'an Hospital Affiliated to Yangzhou University (The Fifth People's Hospital of Huai'an), Huaian, People's Republic of China.
Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Drug Des Devel Ther. 2025 Aug 27;19:7405-7413. doi: 10.2147/DDDT.S544672. eCollection 2025.
This study aims to determine the 90% effective doses (ED) of the initial ropivacaine volume at varying concentrations (0.075%, 0.1%, 0.125%) administered under dural puncture epidural (DPE) for epidural labor analgesia.
Ninety ASA II-class patients with cervical dilation < 5 cm and VAS scores >5 were allocated into three groups (0.075%, 0.1%, and 0.125% ropivacaine concentrations) for epidural labor analgesia. The first patient in each group received an initial bolus of ropivacaine combined with sufentanil 0.3 µg/mL in a 10 mL volume. Subsequent doses were determined by an up-and-down sequential allocation method based on adequate analgesia (VAS score <3) within 30 minutes post-administration, using 2 mL incremental/decremental adjustments. The primary outcome was the ED90s of the initial ropivacaine bolus required for effective analgesia under DPE. Maternal analgesia characteristics and neonatal outcomes were recorded.
The ED90 values for the 0.075%, 0.1%, and 0.125% ropivacaine groups were 13.30 mL (95% CI, 10.00-14.00), 10.80 mL (95% CI, 8.00-12.00), and 8.90 mL (95% CI, 8.00-10.00), respectively. Maternal and neonatal outcomes were comparable across groups.
Compared to 0.075% concentration of ropivacaine, the 0.1% and 0.125% concentrations achieved 18.8% and 33.0% reductions in initial analgesic volume requirements. However, comparable analgesic effects and maternal satisfaction were observed across all groups.
本研究旨在确定在硬膜外穿刺硬膜外麻醉(DPE)下进行硬膜外分娩镇痛时,不同浓度(0.075%、0.1%、0.125%)罗哌卡因初始剂量的90%有效剂量(ED)。
将90例宫颈扩张<5cm且视觉模拟评分(VAS)>5分的美国麻醉医师协会(ASA)Ⅱ级患者分为三组(罗哌卡因浓度分别为0.075%、0.1%和0.125%)进行硬膜外分娩镇痛。每组的第一名患者接受初始剂量的罗哌卡因与0.3μg/mL舒芬太尼混合,体积为10mL。后续剂量通过上下顺序分配法确定,依据给药后30分钟内达到充分镇痛(VAS评分<3)的情况,每次增减2mL进行调整。主要结局是DPE下有效镇痛所需的初始罗哌卡因推注量的ED90。记录产妇的镇痛特征和新生儿结局。
0.075%、0.1%和0.125%罗哌卡因组的ED90值分别为13.30mL(95%可信区间,10.00 - 14.00)、10.80mL(95%可信区间,8.00 - 12.00)和8.90mL(95%可信区间,8.00 - 10.00)。各组产妇和新生儿结局具有可比性。
与0.075%浓度的罗哌卡因相比,0.1%和0.125%浓度的罗哌卡因初始镇痛所需剂量分别减少了18.8%和33.0%。然而,所有组的镇痛效果和产妇满意度相当。